Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
about
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesTowards medication-enhancement of cognitive interventions in schizophreniaTargeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateThe drug treatment of delayed ejaculationA selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of ratsMethotrexate encephalopathy: Two cases in adult cancer patients, who recovered with pathophysiologically based therapy.Are we studying and treating schizophrenia correctly?Pharmacodynamics of memantine: an update.Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signalingRole of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of StrokeThe lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesAmantadine: a review of use in child and adolescent psychiatryVascular cognitive impairment: disease mechanisms and therapeutic implications.Pharmacological tests of hypotheses for acquired pendular nystagmusEffects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slicesNMDA receptors in clinical neurology: excitatory times ahead.Catecholaminergic based therapies for functional recovery after TBIA randomized controlled pilot trial of oral N-acetylcysteine in children with autism.The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate HomeostasisTargets for neuroprotection in Parkinson's diseaseAntinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses.Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.A Validated Stability-indicating Reverse Phase HPLC Assay Method for the Determination of Memantine Hydrochloride Drug Substance with UV-Detection Using Precolumn Derivatization Technique.Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393."Herbal seizures"--atypical symptoms after ibogaine intoxication: a case report.
P2860
Q26747508-62EAD6EB-08AE-407F-B9E5-A9610B018C55Q26860777-C20EB1B7-83B3-4886-B093-0A56D5FF1FABQ27004490-3CF77AC6-F35B-4246-B8C8-5DC1044A7B7AQ28075054-8F1A0E70-099D-4DEB-8189-E1804B3F967EQ28082048-BE3FC0E2-070A-4F47-9A44-283916BE62DBQ28379282-17F6003A-381A-4427-BE55-CAA9B634904CQ30252387-32791529-2A21-41E4-9A29-51C858A17AB7Q30465313-375F7443-5228-4580-AD14-7F030AEECAD3Q30490604-3A536D5E-1176-4B3E-8CAE-07DDAE6C2548Q33428476-1B504D39-9BFE-4FA4-98F4-AFB2CD5914E3Q33565967-F0820AC6-2FA1-4843-972A-350AE422E9F7Q34329204-07A28B0D-21C6-406B-9449-7AC7B4F1239CQ34648021-328EBC12-90F3-4561-AA8A-9045F0E425A6Q35197111-01D364C0-F7D6-4BBB-B56F-DCCABFFEE791Q35278618-38E6F9F7-02A7-4DC2-B33F-A7BB32AB706EQ35873328-F18978C6-C917-427D-A771-413CFEB7165BQ36660216-E82C5B87-23B4-4546-971E-CC8CCD08A171Q36909436-93B14E9F-FA1C-445B-9730-3EC266E3B9FFQ37022453-71B9C270-B317-4A77-9AEE-95D445BC346DQ37062547-711A9F6B-FCD7-4DF3-A736-921E555F7018Q37302453-5B12378B-15BD-49E0-86CE-616669D7586CQ37345125-A75E3AA0-FB29-484F-BA3D-A98D832295F9Q37390908-A9A4B341-5A49-4E36-BB7C-8DE4902517DEQ40170517-F97C3E80-8444-4E3C-A50A-2C757013990EQ42136504-8BFA2A06-51B7-4A97-9A53-CAFAD2141313Q42603795-F13D5064-21CB-4427-BC2D-0F9FC3BCA5BFQ43194387-3265FDDD-C007-4C0C-BEF5-FD0BBDF388B8
P2860
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
@en
type
label
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
@en
prefLabel
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
@en
P2093
P1476
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties
@en
P2093
Riederer P
Schoppmeyer K
P304
P577
1994-01-01T00:00:00Z